HomePYXS • NASDAQ
add
Pyxis Oncology Inc
Previous close
$2.10
Day range
$1.89 - $2.10
Year range
$1.35 - $6.85
Market cap
112.98M USD
Avg Volume
1.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.05M | -6.90% |
Net income | -21.20M | 8.01% |
Net profit margin | — | — |
Earnings per share | -0.35 | 37.50% |
EBITDA | -22.32M | 7.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 144.82M | 8.91% |
Total assets | 195.31M | 4.62% |
Total liabilities | 41.63M | -14.60% |
Total equity | 153.68M | — |
Shares outstanding | 59.47M | — |
Price to book | 0.81 | — |
Return on assets | -28.55% | — |
Return on capital | -31.58% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -21.20M | 8.01% |
Cash from operations | -14.66M | 16.60% |
Cash from investing | -8.00K | -100.12% |
Cash from financing | 1.66M | 1,067.84% |
Net change in cash | -13.02M | -16.41% |
Free cash flow | -6.06M | -166.53% |
About
Founded
2018
Headquarters
Website
Employees
54
